GTBP CIK: 109657

GT Biopharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.6
FY22:
−15.2
FY23:
−8.85
FY24:
−12.9
FY25:
−12.9
Change from FY21 to FY24
millions USD
FY21:
−23.0
FY22:
12.1
FY23:
−2.01
FY24:
12.9
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
42.3
FY22:
−0.22
FY23:
6.27
FY24:
2.98
FY25:
15.8
millions USD
FY21:
3.67
FY22:
−3.30
FY23:
−4.59
FY24:
2.97
FY25:
2.86

All amounts in millions USD Data source:SEC EDGAR